Study Reference No. - C2D01121
Demographic | Gender | Age | Location | Compensation |
---|---|---|---|---|
History of perennial allergic rhinitis (nasal symptoms) to house dust mite for more than 1 year; non-smokers or smokers who are able to refrain from smoking for 6 hours prior to and during each EEC visits. | Males and Females | 18-65 | Mississauga, ON | $2,460 |
Study Details |
|
Study Purpose |
The primary purpose of this study is to compare the effectiveness of Altamira Medica’s AM-301 device (marketed in Europe as Bentrio) between treated and non-treated study participants in the treatment of Perennial Allergic Rhinitis (PAR). |
Study Duration |
5 clinic visits and a follow-up telephone call over approximately 65 days. |
Study Schedule |
|
General Screening |
NA |
Medical Screening |
Mulitiple dates starting 10-November-2021. Contact Recruitment. |
Study Visit(s) |
Multiple cohort dates starting 29-Nov-2021. Contact Recruitment. |
Follow-Up Visit(s) |
N/A |
Other Notes |
|
Bring Valid Photo ID. |
|
COVID-19 test will be conducted prior to designated visits. |